
PwC Notes Capital Concentrating in Scaled, Strategic Trade-Exposed Assets
PwC highlights growing capital concentration in scaled, strategic trade-exposed assets, with implications for chemical capacity

prodchem
Aug 10, 2026

Dow is accelerating efforts to reshape its global manufacturing and supply-chain footprint as part of a broad cost-reduction and productivity program.
The initiative comes as the global chemical industry faces weak demand, excess capacity, high operating costs and continued geopolitical uncertainty. For Dow, improving competitiveness increasingly depends not only on pricing and demand recovery but also on reducing structural costs across its manufacturing network.
The company's Transform to Outperform program is therefore becoming an important part of its strategy. By simplifying operations, improving productivity and optimizing its asset portfolio, Dow aims to create a more efficient supply chain while strengthening long-term profitability.
For chemical procurement teams, these changes matter because manufacturing footprint decisions can affect product availability, lead times, supplier allocation and regional pricing.
Dow launched its Transform to Outperform program to improve productivity, simplify its operating model and strengthen its cost position.
The program includes several areas of focus:
Structural cost reductions
Manufacturing optimization
Portfolio management
Procurement savings
Organizational simplification
Productivity improvements
Asset optimization
The objective is not simply to reduce expenses temporarily. Dow is attempting to create a more competitive cost structure that can perform better across different market cycles.
This is particularly important in commodity chemicals, where relatively small differences in production costs can significantly affect margins.
The chemical industry has entered a period where demand growth alone cannot guarantee profitability.
Global production capacity has expanded significantly, particularly in Asia, while demand in several traditional end markets remains subdued.
At the same time, chemical producers continue to face:
Energy costs
Labor expenses
Maintenance requirements
Logistics costs
Regulatory expenses
Feedstock volatility
For a global producer such as Dow, improving the efficiency of its manufacturing and distribution network can therefore provide a more immediate financial benefit than waiting for a broad global demand recovery.
One of the most important effects of Dow's cost program is the potential restructuring of its manufacturing footprint.
Dow has announced several actions involving facility closures, asset optimization and portfolio changes as it works to reduce structural costs.
The company has also continued evaluating its global asset base to determine which facilities and businesses provide the strongest long-term returns.
From a supply-chain perspective, this creates an important balance:
Lower structural costs vs. maintaining supply reliability
Closing or consolidating facilities can reduce operating expenses, but it can also increase supply-chain concentration.
For customers, the location of remaining production assets becomes increasingly important.
A chemical producer's manufacturing footprint directly influences procurement risk.
When a supplier has multiple production sites, customers may have greater flexibility if one facility experiences:
An outage
Maintenance
Weather disruption
Raw-material shortages
Transportation problems
If production becomes concentrated in fewer locations, the impact of an individual disruption can become larger.
Procurement teams should therefore treat footprint changes as part of supplier-risk management.
There is also a positive side to footprint optimization.
A more focused network can reduce:
Inter-plant transfers
Inventory duplication
Warehousing costs
Transportation complexity
Administrative overhead
Excess capacity
For Dow, simplifying the network can improve asset utilization and reduce the cost of moving products between manufacturing locations and customers.
For buyers, this could eventually translate into more predictable supply and improved service levels if the remaining network is operated efficiently.
Dow operates a global manufacturing network serving customers across North America, Europe, Asia and other markets.
Regional production allows chemical suppliers to reduce dependence on long-distance transportation and serve customers closer to their manufacturing base.
However, regional differences in energy costs and feedstock economics can influence where production is most competitive.
North American assets, for example, can benefit from relatively competitive natural gas and natural gas liquids.
European facilities face a different cost structure because of higher energy costs and greater exposure to naphtha-based feedstocks.
These differences make geographic optimization an important component of Dow's global strategy.
Dow's cost-reduction strategy also has implications for its own procurement operations.
Large chemical companies purchase substantial volumes of:
Raw materials
Feedstocks
Packaging
Maintenance supplies
Industrial services
Logistics services
Energy
Improving procurement efficiency can therefore generate significant savings.
For chemical buyers, this is a reminder that procurement is becoming increasingly integrated with manufacturing strategy.
Supplier selection is no longer simply about obtaining the lowest price.
Companies must evaluate:
Price + Quality + Reliability + Logistics + Capacity + Risk
Dow customers should closely monitor several areas as the transformation progresses.
Facility closures or production changes could affect the availability of selected products.
Changes in production locations may increase or decrease transportation distances and delivery times.
Changes in supply allocation can affect regional price differences.
Greater production concentration could influence commercial terms and minimum order requirements for some products.
Customers should review contracts carefully if manufacturing locations or supply arrangements change.
Cost savings are not limited to manufacturing.
Dow has also been reviewing its product portfolio to determine where it should allocate capital.
Businesses with stronger growth prospects, attractive margins or strategic importance may receive greater investment, while lower-return activities can face restructuring or divestment.
This approach can improve overall profitability but may also change the supplier landscape for customers purchasing products from businesses that are being reviewed.
Global supply-chain decisions are increasingly influenced by geopolitical developments.
Trade restrictions, shipping disruptions and regional conflicts can quickly change the relative attractiveness of different manufacturing locations.
A cost-efficient supply chain must therefore also be resilient.
For Dow, maintaining appropriate geographic diversification is important because a highly concentrated network can be vulnerable to regional disruptions.
For customers, understanding where critical products are manufactured becomes an increasingly important part of supplier intelligence.
Dow's restructuring creates an opportunity for procurement teams to improve their own sourcing strategies.
Customers should:
Map supplier production sites → Identify concentration risks → Qualify alternative suppliers → Compare landed costs → Review inventory strategy
This approach can help buyers respond more quickly if a supplier changes its manufacturing footprint.
It can also create opportunities to negotiate when Dow or other major producers are seeking to improve capacity utilization in specific regions.
An important distinction for buyers is that producer cost savings do not automatically translate into lower selling prices.
If Dow reduces manufacturing costs while market prices remain stable, the immediate benefit may appear primarily in the company's margins.
However, if cost reductions improve competitiveness and allow Dow to operate assets at higher utilization rates, the longer-term effect could be greater supply availability.
The impact on customers will therefore depend on market conditions and competitive dynamics.
Dow's transformation is likely to remain an important strategic theme as the company navigates a challenging global chemical environment.
The focus on cost reduction, productivity and asset optimization should help the company improve its resilience during periods of weak demand.
At the same time, customers will need to monitor how manufacturing changes affect regional supply, logistics and product availability.
The biggest question is whether Dow can reduce structural costs without creating excessive supply-chain concentration.
Dow's cost savings program is doing more than reducing expenses. It is helping reshape the company's global manufacturing and supply-chain footprint.
Through productivity improvements, asset optimization, portfolio management and network simplification, Dow is working to create a more competitive and efficient operating structure.
For chemical procurement teams, the transformation highlights an important principle: supplier cost restructuring can directly affect supply-chain risk.
Changes in manufacturing locations, production allocation and capacity can influence product availability, lead times, freight costs and regional pricing.
As Dow continues its transformation, buyers should closely monitor its manufacturing footprint and incorporate supplier-ownership, capacity and facility intelligence into their sourcing strategies.
In an increasingly volatile chemical market, understanding where a supplier produces, how it manages capacity, and how its cost structure is changing can be just as important as knowing the price on today's quotation.

Featured Product

Found this useful?
Continue Reading

PwC highlights growing capital concentration in scaled, strategic trade-exposed assets, with implications for chemical capacity

Eastman's working-capital normalization signals improving supply-chain visibility, inventory balance and trade-flow predictability for global chemical procurement.

Lone Star Funds' acquisition of Lonza's capsules business highlights investor confidence in pharmaceutical supply-chain resilience